NMR LipoProfile
Overview:
LDL Particle Number
LDL Particle Number (LDL-P) directly quantifies the concentration (number) of LDL particles circulating in the blood. Like ApoB, this is considered a key driver of atherosclerosis, as risk is more closely related to the number of particles available to penetrate the arterial wall than the total cholesterol they carry. Lowering LDL-P is a primary goal for cardiovascular risk reduction in longevity-focused strategies. Ranges assume no underlying medical conditions such as prior heart disease.
Small LDL Particle Number
Small LDL Particle Number (Small LDL-P) specifically quantifies the concentration of small, dense LDL particles. These particles are considered particularly atherogenic due to their ease of oxidation and penetration into the arterial wall, and they are strongly associated with insulin resistance and increased cardiovascular risk. Minimizing this subfraction is a key target in advanced lipid management.
LDL Size
LDL Peak Size measures the average diameter of LDL particles in Angstroms (Å). Smaller LDL particle size (often corresponding to Pattern B) is linked to higher cardiovascular risk. Larger particle size (Pattern A) is generally considered more favorable. This measurement complements LDL particle number (LDL-P) by providing information on particle characteristics.
HDL-P (Total)
Total HDL Particle Number (HDL-P) measures the concentration (number) of HDL particles in the blood. Similar to Apo A-I, it reflects the quantity of HDL particles available for reverse cholesterol transport. Higher HDL-P is generally associated with lower cardiovascular risk, providing a different perspective than HDL-C (cholesterol content).
HDL Large Particle Number
HDL Large Particle Number (HDL-L) directly quantifies the concentration (number) of large HDL particles circulating in the blood. Like ApoB, this is considered a key driver of atherosclerosis, as risk is more closely related to the number of particles available to penetrate the arterial wall than the total cholesterol they carry. Lowering HDL-L is a primary goal for cardiovascular risk reduction in longevity-focused strategies. Ranges assume no underlying medical conditions such as prior heart disease.
Categories
Preparation
$38